NCT03875144 2026-02-09MESOTIPInstitut du Cancer de Montpellier - Val d'AurellePhase 2 Suspended66 enrolled
NCT01088620 2013-03-14Panitumumab Plus Pemetrexed and Cisplatin (PemCisP) Versus PemCis in the First-line Treatment of Patients With Non-small Cell Lung CancerWiSP Wissenschaftlicher Service Pharma GmbHPhase 2 Suspended134 enrolled